Hylife Biotech, an established Australian life sciences entity, has been diligently serving its members for numerous years, aiming to advance the global expansion of the Australian life sciences sector by offering representation and essential services.
With a robust network comprising over 3,000 members across various life sciences fields such as therapeutics, medical technology, digital health, and agri-biotech, Hylife Biotech fosters connectivity and collaboration. With representation in every Australian state, the organization ensures a nationwide support network to facilitate members' endeavors and facilitate the commercialization of Australian life science innovations in both domestic and global markets.
Hylife Biotech is committed to fostering the advancement, expansion, and success of the Australian life science sector. This dedication is demonstrated through initiatives aimed at promoting sustainability and development, facilitating market access and outreach, and offering comprehensive representation and assistance to members both domestically and internationally.
We maintain robust ties with the government and encourage members to contribute their viewpoints and expertise. We actively push for policy adjustments in areas such as taxation, clinical trials, intellectual property, regulation, and beyond, aiming to uphold Australia's competitive edge in the global life sciences arena.
Life science enterprises face distinct vulnerabilities, and securing capital is essential for fostering the sector's growth and advancement. We are dedicated to facilitating connections between companies and investors, enhancing individuals' skills to navigate the investment and life sciences landscape effectively, and advocating for the preservation of tax incentive policies that enable companies to access vital capital.
Sign up to stay up to date with upcoming Hylife Biotech events